← Back to Search

Participants With Inherited Retinal Diseases (IRDs) for Inherited Retinal Disease (EYERD Registry Trial)

N/A
Recruiting
Research Sponsored by Janssen Research & Development, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 8 years
Awards & highlights

EYERD Registry Trial Summary

The purpose of this study is to better understand the natural history of Inherited Retinal Disease (IRD) and help inform patient management.

Eligible Conditions
  • Inherited Retinal Disease

EYERD Registry Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 8 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 8 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Acuity (VA)
Visual Field (VF)
Secondary outcome measures
Achromatopsia (ACHM) Symptom and Impact Diary
Achromatopsia (ACHM) Vision Impact Questionnaire (AVIQ)
Association Between IRD Genotype and Change in Visual Acuity
+22 more

Side effects data

From 2016 Phase 4 trial • 8 Patients • NCT01833897
38%
sedation
25%
headache
13%
phosphenes
13%
hypomania
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ketamine and DCS Treatment

EYERD Registry Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants With Inherited Retinal Diseases (IRDs)Experimental Treatment1 Intervention
Adult and pediatric (greater than or equal to [>=] 3 years) participants with a documented genetic diagnosis of X-linked retinitis pigmentosa (XLRP) or Achromatopsia (ACHM) and any signs or symptoms of IRD or documented retinal changes detected by imaging or electrophysiology.

Find a Location

Who is running the clinical trial?

Janssen Research & Development, LLCLead Sponsor
975 Previous Clinical Trials
6,377,308 Total Patients Enrolled
Janssen Research & Development, LLC Clinical TrialStudy DirectorJanssen Research & Development, LLC
745 Previous Clinical Trials
3,952,905 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Global Patient Registry of Inherited Retinal Diseases
2023. "Global Patient Registry of Inherited Retinal Diseases". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05957276.
~4667 spots leftby May 2031
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top